Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin

E-ISSN： 1875-533x|13|11|1337-1357

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.11, 2006-05, pp. : 1337-1357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of New Oxazaphosphorine Anticancer Drugs

Current Pharmaceutical Design, Vol. 13, Iss. 9, 2007-03 ,pp. : 963-978

Bentham Science Publishers

Access to resources Recommend Favorite

New-generation platinum drugs in the treatment of cisplatin-resistant cancers

By McKeage Mark J

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1033-1046

Informa Healthcare

Access to resources Recommend Favorite

Biomolecular Targets for Platinum Antitumor Drugs

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 2, 2002-04 ,pp. : 103-111

Bentham Science Publishers

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite

Pentavalent Antimonials: From Chemistry to the Design of New Drugs

Drug Design Reviews - Online, Vol. 2, Iss. 3, 2005-05 ,pp. : 243-249

Bentham Science Publishers

Access to resources Recommend Favorite